Viveve Medical, Inc. (VIVE)
OTCMKTS: VIVE · Delayed Price · USD
0.0003
0.00 (0.00%)
Apr 19, 2024, 11:51 AM EDT - Market closed
Viveve Medical Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Year | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 - 1990 |
---|---|---|---|---|---|---|---|---|---|---|---|
Cash & Equivalents | 19.16 | 6.52 | 13.31 | 29.52 | 20.73 | 8.09 | 7.36 | 0.9 | 0.77 | 0.26 | Upgrade
|
Cash & Cash Equivalents | 19.16 | 6.52 | 13.31 | 29.52 | 20.73 | 8.09 | 7.36 | 0.9 | 0.77 | 0.26 | Upgrade
|
Cash Growth | 193.76% | -50.98% | -54.92% | 42.42% | 156.37% | 9.86% | 722.35% | 16.38% | 198.06% | -90.02% | Upgrade
|
Receivables | 0.55 | 0.77 | 1.57 | 5.7 | 6.21 | 2.09 | 0.59 | 0.01 | 0.5 | 0.4 | Upgrade
|
Inventory | 1.47 | 3.25 | 4.86 | 4.12 | 2.39 | 2.69 | 1.55 | 0.13 | 0.12 | 0.18 | Upgrade
|
Other Current Assets | 1.06 | 2.3 | 2.45 | 2.56 | 2.74 | 1.07 | 1.62 | 0.92 | 0.13 | 0.18 | Upgrade
|
Total Current Assets | 22.24 | 12.84 | 22.19 | 41.9 | 32.07 | 13.93 | 11.12 | 1.96 | 1.52 | 1.02 | Upgrade
|
Property, Plant & Equipment | 1.55 | 2.76 | 3.05 | 2.92 | 1.3 | 0.48 | 0.24 | 0.19 | 0.04 | 0.07 | Upgrade
|
Long-Term Investments | 0.58 | 0.83 | 1.22 | 1.84 | 2.5 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
Other Long-Term Assets | 1.54 | 0.2 | 0.53 | 0.17 | 0.2 | 0.14 | 0.14 | 0.16 | 0 | 0 | Upgrade
|
Total Long-Term Assets | 3.68 | 3.79 | 4.79 | 4.93 | 4.01 | 0.62 | 0.38 | 0.34 | 0.04 | 0.07 | Upgrade
|
Total Assets | 25.91 | 16.63 | 26.98 | 46.83 | 36.08 | 14.55 | 11.49 | 2.3 | 1.56 | 1.09 | Upgrade
|
Accounts Payable | 1.48 | 0.88 | 1.61 | 3.99 | 4.8 | 3.09 | 1.43 | 0.42 | 0.43 | 0.38 | Upgrade
|
Deferred Revenue | 0.45 | 0.38 | 0.77 | 0.69 | 0 | 0 | 0 | 0 | 0 | 0.32 | Upgrade
|
Current Debt | 0.23 | 0.92 | 0.27 | 0 | 0 | 1.87 | 4.83 | 2.5 | 0 | 0 | Upgrade
|
Other Current Liabilities | 2.38 | 2.04 | 3.66 | 6.08 | 4.61 | 2.19 | 1.29 | 0.22 | 0.56 | 0.45 | Upgrade
|
Total Current Liabilities | 4.53 | 4.22 | 6.31 | 10.76 | 9.4 | 7.14 | 7.56 | 3.14 | 0.98 | 1.14 | Upgrade
|
Long-Term Debt | 5.12 | 4.94 | 3.98 | 30.53 | 28.95 | 7.76 | 0 | 0 | 4.54 | 8.1 | Upgrade
|
Other Long-Term Liabilities | 1.19 | 0.5 | 0.17 | 0.63 | 0.33 | 0.05 | 0 | 0 | 2.68 | 3.8 | Upgrade
|
Total Long-Term Liabilities | 6.31 | 5.44 | 4.15 | 31.16 | 29.28 | 7.82 | 0 | 0 | 7.22 | 11.9 | Upgrade
|
Total Liabilities | 10.85 | 9.66 | 10.46 | 41.92 | 38.68 | 14.95 | 7.56 | 3.14 | 8.2 | 13.04 | Upgrade
|
Total Debt | 5.35 | 5.86 | 4.25 | 30.53 | 28.95 | 9.63 | 4.83 | 2.5 | 4.54 | 8.1 | Upgrade
|
Debt Growth | -8.74% | 37.87% | -86.08% | 5.46% | 200.63% | 99.23% | 93.32% | -44.90% | -43.97% | 52.02% | Upgrade
|
Common Stock | 0 | 0 | 0 | 160.3 | 102.98 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
Retained Earnings | -241.85 | -219.83 | -197.91 | -155.39 | -105.58 | -68.62 | -48.51 | -36.09 | -103.62 | -107.11 | Upgrade
|
Comprehensive Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.27 | -0.27 | Upgrade
|
Shareholders' Equity | 15.07 | 6.97 | 16.52 | 4.91 | -2.6 | -0.41 | 3.94 | -0.84 | -6.64 | -11.95 | Upgrade
|
Total Liabilities and Equity | 25.91 | 16.63 | 26.98 | 46.83 | 36.08 | 14.55 | 11.49 | 2.3 | 1.56 | 1.09 | Upgrade
|
Net Cash / Debt | 13.81 | 0.66 | 9.06 | -1.01 | -8.22 | -1.54 | 2.53 | -1.61 | -3.77 | -7.84 | Upgrade
|
Net Cash / Debt Growth | 1986.56% | -92.69% | - | - | - | - | - | - | - | - | Upgrade
|
Net Cash Per Share | 1.37 | 0.42 | 72.58 | -32.36 | -469.71 | -167.32 | 503.19 | -712.70 | -24153.85 | -196000.00 | Upgrade
|
Working Capital | 17.71 | 8.63 | 15.88 | 31.14 | 22.67 | 6.79 | 3.56 | -1.18 | 0.53 | -0.12 | Upgrade
|
Book Value Per Share | 1.49 | 4.43 | 132.40 | 158.15 | -148.61 | -43.92 | 783.75 | -373.45 | -42576.92 | -298675.00 | Upgrade
|
Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.